Another comprehensive study on this topic also addressed the role of MAGL in the interplay between cancer and immune cells and found that arsenite resistance protein 2 (ARS2) transcriptionally upregulates MAGL and thereby regulates the self-renewal and tumourigenicity of glioma stem cells via increased synthesis of PGE2 [163]. The gene discussed is SRRT; the disease is central nervous system cancer.